Focus Groups in Ethnically and Racially Diverse Families

Attention Deficit/Hyperactivity Disorder Clinical Trial

Official title:

Focus Groups to Optimize Research Methodology in a Multinutrient Study of Racially and Ethnically Diverse Children With ADHD and Emotional Dysregulation

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05930886
• Other study ID #: 00024335
• Status: Recruiting
• Start date: April 15, 2023
• Est. completion date: June 30, 2024

Study information

• Verified date: May 2024
• Source: Oregon Health and Science University
• Contact: Jeanette Johnstone, PhD
• Phone: 503-494-3700
• Email: jojeanet[@]ohsu.edu
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Focus groups to identify treatment needs and barriers to participation in the planned multinutrient study among racially and ethnically diverse (Black and Hispanic) communities.

Description:

Focus group purpose is to understand parents' priorities regarding their child's mental health, and facilitators or barriers to research participation generally, with inquiry about CIH intervention use, and the multinutrient feasibility study specifically. Researchers will engage Black and Hispanic families in focus groups to discuss mental health priorities related to their children, and real or perceived barriers to engagement in research studies. The feedback will inform the final design and recruitment for the multinutrient feasibility study in Black and Hispanic populations. One group will comprise individuals who self-identify as Hispanic, another, as Black, in order to create space to hear perspectives that may differ between broadly defined groups.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: June 30, 2024
• Est. primary completion date: May 30, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Adult parents/caregivers self-identified as Black or Hispanic/Latino

• With a family member 6-18 years old with suspected ADHD and/or emotional dysregulation, or provide care for, or teach someone who meets these criteria

• Who have sought or are interested in treatment

• Willing to discuss child's mental health care needs and provide feedback regarding feasibility study

• Able to attend focus groups in person

• Able to communicate in English or Spanish

• Agree to focus group session audio recording

Exclusion Criteria:

• Unwilling to be recorded

Related Conditions & MeSH terms

• Attention Deficit Disorder with Hyperactivity
• Attention Deficit/Hyperactivity Disorder
• Emotional Dysfunction
• Irritable Mood

Intervention

Other:
• Focus Group
Black or Hispanic/Latino parents, caregivers or family members of children with ADHD symptoms and/or emotional dysregulation, will discuss: (1) impact of child's mental health, treatments, care received; (2) perceived and actual barriers to future study participation, including discussion about acceptability of bio-specimen collection methods for urine and blood. Each group will comprise individuals who self-identify as Hispanic/Latino, Black, or mixed race. Groups are anticipated to comprise individuals who identify with one or the the other race/ethnicity in order to create space to hear perspectives that may differ between these broadly defined groups.

Locations

Country	Name	City	State
United States	Oregon Health & Science University	Portland	Oregon

Sponsors (1)

Lead Sponsor	Collaborator
Oregon Health and Science University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Input and Feedback on Proposed Feasibility Study	Purpose is understanding; Parents' priorities regarding their child's mental health; Facilitators or barriers to research participation generally; Parent input on planned study specifically; Specific recommendations for modifying the future feasibility study design; Previous CIH intervention use	Baseline